FHTX R&D to Revenue
Foghorn Therapeutics Inc · R&D to Revenue
FHTX R&D to Revenue
Latest reported276.51%period ending
FHTX FY R&D/Revenue (0.00% → 276.51%)
Latest values, visible window
High-resolution chart · PNG
FHTX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 276.5085% | |
| 418.2285% | |
| 321.1506% | |
| 549.2927% | |
| 6,089.8408% | |
| 13,422.093% | |
| 0% | |
| 0% |